Following Mtb-antigen stimulation, patients with LTBI-T2DM showed lower frequencies of CD8+ Tc1, Tc2, and Tc17 cells, with elevated cytotoxic markers (perforin and granzymes) than those without T2DM and reversing upon ATB development (90). This evidence concerns the gene CD8A and type 2 diabetes mellitus.